News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
AOL.com Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cardlytics, Inc. reported its quarter-ended 2026 results, showing a significant decline in revenue to $36.88M and a net loss of ($14.88M), resulting in a diluted loss per share of ($1.5). These declines are attributed to lower marketer activity and the exit of a major …
Cardlytics (NASDAQ: CDLX) reported a significant decline in Q2 2026 revenue to $36.9 million from $58.0 million a year prior, primarily due to a U.S. financial-institution partner exiting its platform and a decrease in Monthly Qualified Users (MQUs). The company posted a total net …
Cardlytics, Inc. reported its financial results for the second quarter and six months ended June 30, 2026. The company experienced a decrease in sales and an increase in net loss for the second quarter compared to the previous year. For the six-month period, sales …
The article discusses CDLX's valuation, highlighting that it appears 77.0% undervalued based on GuruFocus's GF Value™ metric, despite facing challenging future prospects. This suggests a potential disconnect between the company's current market price and its intrinsic value as calculated by GuruFocus.
CARDLYTICS ($CDLX) reported its Q2 2026 earnings, missing both earnings per share and revenue estimates. The company posted -$1.50 EPS against an estimated -$1.38, and revenue of $36.88 million, missing the $37.74 million estimate. Following the announcement, the stock price saw a decline of …
Cardlytics (NASDAQ: CDLX) reported a net loss of $14.9 million in Q2 2026, with revenue decreasing 36% year-over-year to $36.9 million. The company's Monthly Qualified Users (MQUs) also fell by 17% to 185.4 million, compared to 224.5 million in Q2 2025. Despite these declines, …
Cardlytics, Inc. announced an inducement grant of 50,000 restricted stock units (RSUs) to its new Chief Legal Officer, Chris Cheng. These RSUs will vest over 24 months, with half vesting on September 1, 2027, and the remainder vesting quarterly over the subsequent 12 months, …
Cardlytics, Inc. announced an inducement grant of 10,320 restricted stock units to 10 newly hired employees on July 29, 2026. These grants were made under the Cardlytics, Inc. 2022 Inducement Plan and in accordance with Nasdaq Listing Rule 5635(c)(4). The restricted stock units will …
Cardlytics recently granted 10,320 restricted stock units (RSUs) to 10 new employees on July 29, 2026, under its 2022 Inducement Plan. Half of these RSUs will vest on the first anniversary of the grant date, with the remaining portion vesting quarterly over the subsequent …
The article provides an analysis of Cardlytics Inc.'s (CDLX) financial health, noting its weak financial status and average operating efficiency. The company's financial score is 6.16, ranking 395 out of 486 in the Software & IT Services industry. It highlights a significant year-over-year decrease …
This article provides a technical analysis of Cardlytics Inc (CDLX), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. CDLX currently has a price momentum score of 4.46, trades between support at $3.34 and resistance at $4.41, …
Cardlytics Inc. has appointed a new chief legal officer, formerly from Zoom and EBay, who is set to begin on Monday next week. The new CLO identifies data privacy and increasingly complex government regulations as major challenges in the role.
Cardlytics Inc (CDLX) currently holds an institutional shareholding score of 3.00, placing it 283rd out of 485 in the Software & IT Services industry. The institutional shareholding proportion is 36.29%, a decrease of 39.44% quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.20% …
Cardlytics Inc. has announced the appointment of Chris Cheng as its new Chief Legal Officer, effective August 3, 2026. Cheng brings over 20 years of legal experience from high-growth technology companies like Zoom and Uber, and will be a key part of Cardlytics' leadership …
This article provides a comprehensive stock analysis of Cardlytics Inc (CDLX) by TradingKey, highlighting its stable fundamentals, significant growth potential, and "fairly valued" status within the Software & IT Services industry. Despite recent weak market performance, the company shows strong fundamentals and institutional confidence. …
Cardlytics Inc (CDLX) has not distributed any dividends over the past five years. The company has, however, had a stock split event in May 2026, which was a 10-for-1 merger. This article provides a historical overview of CDLX's dividend payouts and stock split timeline.
Cardlytics, Inc. (LSE:0LEC) generated $233.27 million in revenue last year, with its Cardlytics Platform segment being the top performer at $212.33 million. The United States was the primary contributor to revenue, accounting for $202.97 million. These figures indicate a slight decrease from the previous …
Cardlytics (CDLX) announced it will release its Q2 financial results on August 5, 2026, projecting revenues between $35 million and $40 million despite the loss of Bank of America as a partner. While GuruFocus identifies CDLX as 79.1% undervalued with a GF Value™ of …
Cardlytics stock performance reflects a business undergoing restructuring, with Q1 2024 revenue stabilizing at around $65 million, a 10% year-over-year increase. The company has focused on cost discipline, narrowing its operating loss to $12 million in Q1 2024, down from $20 million in Q1 …
This article provides access to a discussion forum for Cardlytics (CDLX) stock. It features various sections including stock quotes, charts, historical data, news, and financial analysis tools for investors to engage and share insights about the company's performance.
This article provides a bond risk profile for Cardlytics, Inc. 4.25% 01-APR-2029 bond, identified as CDLX6046219. It highlights key metrics for risk analysis, including security level, inflation protection, and issuer rating, to help investors evaluate the bond's reliability. The page also mentions the availability …
This article provides a bond profile for Cardlytics, Inc. 4.25% 01-APR-2029, identified as CDLX6046219. It details key metrics such as the issuer, issue and maturity dates, outstanding amount, face value, and coupon rate. The profile also includes a brief business description of Cardlytics, Inc., …
This article provides a profile of the CDLX6046219 bond, specifically detailing its coupon rate and payment schedule. The bond, issued by Cardlytics, Inc., has a current coupon rate of 4.25%, with the next interest payment scheduled for October 1, 2026. It highlights the availability …
Search by ticker symbol or company name and select a result to open its chart.